Method of levels therapy for first-episode psychosis: The feasibility randomized controlled Next Level trial

被引:5
|
作者
Griffiths, Robert [1 ,2 ]
Mansell, Warren [1 ]
Carey, Timothy A. [3 ]
Edge, Dawn [4 ]
Emsley, Richard [5 ]
Tai, Sara J. [1 ]
机构
[1] Univ Manchester, Fac Biol Med & Hlth, Div Psychol & Mental Hlth, Sch Psychol Sci, Manchester, Lancs, England
[2] Greater Manchester Mental Hlth NHS Fdn Trust, Psychosis Res Unit, Rico House,George St, Manchester M25 9WS, Lancs, England
[3] Flinders Univ S Australia, Ctr Remote Hlth, Alice Springs, NT, Australia
[4] Univ Manchester, Ctr Remote Hlth, Manchester, Lancs, England
[5] Inst Psychiat, Dept Biostat & Hlth Informat, London, England
关键词
early intervention; feasibility; first-episode psychosis; Method of Levels; psychotherapy; randomized controlled trial; COGNITIVE-BEHAVIORAL THERAPY; PERCEPTUAL CONTROL-THEORY; PSYCHOLOGICAL CHANGE; EARLY INTERVENTION; SCHIZOPHRENIA; PEOPLE; METAANALYSIS; DISORDERS; SERVICES; UTILITY;
D O I
10.1002/jclp.22820
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective We aimed to determine the feasibility and acceptability of Method of Levels (MOL) for people experiencing first-episode psychosis (FEP) to inform decision making about the therapy's suitability for further testing in a larger clinical trial. Method A parallel group randomized controlled trial design was used. Participants (N = 36) were allocated to receive either treatment as usual (TAU) or TAU plus MOL. Recruitment and retention in the trial and the acceptability of the MOL intervention were the primary outcomes. Results The recruitment target was met within the planned time frame. Retention in the trial at final follow-up was 97%, substantially higher than the 80% threshold prespecified as a successful feasibility outcome. Participant feedback provided initial evidence of the acceptability of the study design and intervention for this population. Conclusion Results support progressing to a larger trial of MOL for FEP. Recommendations for the design of future trials are provided.
引用
收藏
页码:1756 / 1769
页数:14
相关论文
共 50 条
  • [41] Effectiveness of group cognitive-behaviour therapy for first episode psychosis - Results of a randomized controlled trial
    Lecomte, T.
    Leclerc, C.
    Wykes, T.
    Wallace, C. J.
    Spidel, A.
    Greaves, C.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 440 - 440
  • [42] 'It was me answering my own questions': Experiences of method of levels therapy amongst people with first-episode psychosis
    Griffiths, Robert
    Mansell, Warren
    Edge, Dawn
    Carey, Timothy A.
    Peel, Heather
    Tai, Sara J.
    INTERNATIONAL JOURNAL OF MENTAL HEALTH NURSING, 2019, 28 (03) : 721 - 734
  • [43] A randomized controlled trial of a brief intervention for families of patients with a first episode of psychosis
    Leavey, G
    Gulamhussein, S
    Papadopoulos, C
    Johnson-Sabine, E
    Blizard, B
    King, M
    PSYCHOLOGICAL MEDICINE, 2004, 34 (03) : 423 - 431
  • [44] Plasma prolidase levels are high in schizophrenia but not in first-episode psychosis
    Bolu, Abdullah
    Uzun, Ozcan
    Aydin, Mikail Burak
    Ertugrul, Sebla
    Oznur, Taner
    Cetinkaya, Serdar
    Erdem, Onur
    Ozmenler, Kamil Nahit
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021, 36 (01) : 25 - 29
  • [45] Suicidal behaviour and mortality in first-episode psychosis: the OPUS trial
    Bertelsen, Mette
    Jeppesen, Pia
    Petersen, Lone
    Thorup, Anne
    Ohlenschlaeger, Johan
    Le Quack, Phuong
    Christensen, Torben Ostergaard
    Krarup, Gertrud
    Jorgensen, Per
    Nordentoft, Merete
    BRITISH JOURNAL OF PSYCHIATRY, 2007, 191 : S140 - S146
  • [46] Comparison of olanzapine, quetiapine, and risperidone in first-episode psychosis: A randomized, 52-week trial
    McEvoy, J.
    Lieberman, J.
    Perkins, D.
    Gu, H.
    Hamer, R.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S271 - S271
  • [47] The credibility and acceptability of befriending as a control therapy in a randomized controlled trial of cognitive behaviour therapy for acute first episode psychosis
    Bendall, Sarah
    Jackson, Henry J.
    Killackey, Eoin
    Allott, Kelly
    Johnson, Tracy
    Harrigan, Susan
    Gleeson, John
    McGorry, Patrick D.
    BEHAVIOURAL AND COGNITIVE PSYCHOTHERAPY, 2006, 34 (03) : 277 - 291
  • [48] A systematic review of relapse measurement in randomized controlled trials of relapse prevention in first-episode psychosis
    Gleeson, John F. M.
    Alvarez-Jimenez, Mario
    Cotton, Sue M.
    Parker, Alexandra G.
    Hetrick, Sarah
    SCHIZOPHRENIA RESEARCH, 2010, 119 (1-3) : 79 - 88
  • [49] Comparison of olanzapine, quetiapine, and risperidone in first-episode psychosis: A randomized 52-week trial
    McEvoy, JP
    Lieberman, JA
    Perkins, D
    Hamer, RM
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 22 - 22
  • [50] Treatment of enduring positive symptoms in first-episode psychosis: A randomised controlled trial of CBT and clozapine
    Edwards, J
    Maude, D
    McGorry, P
    Cocks, J
    Burnett, P
    Davern, M
    Bennett, C
    Harrigan, S
    Herman, T
    Wade, D
    Bell, R
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 278 - 278